Bioretec Oy (BRETEC) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Bioretec Oy stock €0.02, price €0.02, that is 6.0% below the price, quality 25 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Bioretec Oy
BRETEC · HEThe stock is already about fairly priced and weak company.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
60‑month range €0.0116 – €3.26 · fair‑value band €0.0218 – €0.0241 · the €0.0244 price screens above the €0.0229 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether Bioretec Oy is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide.
Show moreShow less
The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery.
It also provides ActivaScrew Cannulated that offers a range of fully threaded and partially threaded cannulated screws for fixation of fractures and osteotomies; ActivaScrew Interference, a tool for multiple uses regarding bone fractures, osteotomies, arthrodesesm, and bone grafts; ActivaScrew Interference TCP, a biocomposite interference screw; and RemeOs Screw, a magnesium screw implants.
The company was formerly known as BCI Bioabsorbable Concepts Oy. The company was incorporated in 1998 and is headquartered in Tampere, Finland.
Stock analysis
Bioretec Oy (BRETEC) currently trades at €0.0244, while our estimate is €0.0229, so the stock looks roughly fairly valued today (gap 6.4%).
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: €0.0218 (bear) to €0.0241 (bull), the price of €0.0244 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 25/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Bioretec Oy reported revenue of €3.5M in FY2025 versus €2.0M in FY2021, a compound +15.2%/yr. Reported net income was −€9.5M in FY2025.
Key figures
Market cap €32.7M Micro · EPS (TTM) €−0.0200 · Return on equity −4,861% · Return on assets (EBIT) −47.2% (5-year average) · Free cash flow −€10.3M · Net debt €506K.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 41 out of 100 (low confidence).
What moves the price
The share trades about 97% below its 52-week high and 110% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −16% fair-value upside, at −6%, BRETEC screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch BRETEC, get fair value alerts →
Compare Bioretec Oy with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 401 stocks
Valuation Multiplesvs Medical Devices median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Fair value gap by industry
- Return on assets by industry
- PEG screener for stocks with fair value
- Valuation of the Finland market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| DexCom, Inc DXCM | $81.61 | $91.66 | +12% | vs BRETEC |
| Boston Scientific Corporation BSX | $43.69 | $48.77 | +12% | vs BRETEC |
| Stryker Corporation SYK | $310.72 | $340.60 | +10% | vs BRETEC |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥184.30 | ¥197.34 | +7% | vs BRETEC |
| GE HealthCare Technologies Inc GEHC | $82.96 | $69.92 | −16% | vs BRETEC |
| Siemens Healthineers AG SHL | €44.00 | €34.51 | −22% | vs BRETEC |
| Edwards Lifesciences Corporation EW | $107.11 | $81.94 | −24% | vs BRETEC |
| Medtronic plc MDT | $102.88 | $74.89 | −27% | vs BRETEC |
| Abbott Laboratories, ABT | $107.45 | $75.28 | −30% | vs BRETEC |
| Koninklijke Philips N.V PHIA | €27.54 | €15.23 | −45% | vs BRETEC |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Bioretec Oy (BRETEC) overvalued or undervalued?
What is the fair value of BRETEC?
What is the quality score of BRETEC?
What is the price target for Bioretec Oy (BRETEC)?
What is the Bioretec Oy stock forecast for 2026?
What is the intrinsic value of Bioretec Oy (BRETEC)?
Is Bioretec Oy stock overvalued or undervalued in 2026?
Is fair value the same as the market price of BRETEC?
How much is Bioretec Oy worth?
What do the bullish and bearish scenarios say about BRETEC?
How solid is the balance sheet of Bioretec Oy (BRETEC)?
How far is BRETEC from its 52-week high?
Which stocks are comparable to Bioretec Oy?
Is Bioretec Oy stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Bioretec Oy (BRETEC)?
What should I pay attention to with Bioretec Oy right now?
Key figures of Bioretec Oy
How large is the market capitalisation of Bioretec Oy (BRETEC)?
What are the earnings per share of Bioretec Oy (BRETEC)?
What is the return on equity of Bioretec Oy (BRETEC)?
What is the EBIT return on assets of Bioretec Oy (BRETEC)?
How much free cash flow does Bioretec Oy (BRETEC) generate?
How much net debt does Bioretec Oy (BRETEC) carry?
Watch Bioretec Oy in the live analysis
One click puts Bioretec Oy on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.